[1] Lee H A, Lee D Y, Cho H M, et al. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension[J]. Circulation research, 2013, 112(7): 1004-1012.
[2] Kosaka H, Hirayama K, Yoda N, et al. The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family[J]. European journal of pharmacology, 2010, 635(1-3): 49-55.